6Th Skin Pharmaceuticals Private Limited
Produces chemical substances for pharmaceuticals, including scalp lotions, moisturizers, and skin lightening creams.
2013 | Tiruvallur, Tamil Nadu (India) | Active
6Th Skin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 3.50 M
- Revenue Growth 9.28%
- Profit Growth -111.49%
- Ebitda -115.18%
- Net Worth -352.71%
- Total Assets -12.10%
About 6Th Skin Pharmaceuticals
6Th Skin Pharmaceuticals Private Limited (6SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2013 and has a history of 11 years and eight months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 M.
Dhandapani Devi and Soundararajan Deepa serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233TN2013PTC091841
- Company No.
091841
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2013
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Chemicals and Materials
Who are the key members and board of directors at 6Th Skin Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhandapani Devi  | Director | 25-Jun-2013 | Current |
| Soundararajan Deepa | Director | 25-Jun-2013 | Current |
Financial Performance of 6Th Skin Pharmaceuticals.
6Th Skin Pharmaceuticals Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 9.28% increase. The company also saw a substantial fall in profitability, with a 111.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 352.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 6Th Skin Pharmaceuticals?
In 2016, 6Th Skin Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹3.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- The Karnataka Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2015 | The Karnataka Bank Limited | ₹3.50 M | Open |
How Many Employees Work at 6Th Skin Pharmaceuticals?
6Th Skin Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 6Th Skin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 6Th Skin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
